Today's fishwrap editorial .....
https://www.startribune.com/covid-treatment-warrants-fresh-look/600143855/"But on Dec. 21, Johns Hopkins-led researchers posted their findings from a multicenter trial involving 1,181 patients. Unlike many other studies, they were given concentrated convalescent plasma early, not when seriously ill. The research, posted to the preprint website MedRxiv, found:
"With early administration of high-titer SARS-CoV-2 convalescent plasma reducing outpatient hospitalizations by more than 50%, our findings suggest that this is another effective treatment for COVID-19 with the advantages being low cost, wide availability and rapid resilience to the evolving SARS-CoV-2," Johns Hopkins researcher Dr. Kelly Gebo stated.
Dr. Claudia Cohn, a University of Minnesota Medical School professor and transfusion medicine researcher, called the new findings "really good strong data." She said it would be helpful for leaders in Washington, D.C., to ask questions about the new findings and how to boost plasma supplies."
The study ?
"Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma"
Funding ? Oh.
"Funding: This study was funded principally by the U.S. Department of Defense’s (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), in collaboration with the Defense Health Agency (DHA) (contract number: W911QY2090012) ........."
"This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice."
Peer reviewed ? Nah. Good to go tho. Cuz we say so, and disregard that study that was not funded by DoD, or peer reviewed. 🤣🤣
RecentWTF is wrong with the lef... by Reacher
TOTTM 2026
by murphstahoe WTF is the deal with the ... by Somewhere in Mn
Total Members: 142